These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1650871)

  • 21. [Neurobiology of addiction to drugs of abuse].
    Gil-Verona JA; Pastor JF; de Paz F; Barbosa M; Macias-Fernández JA; Maniega MA; Rami-González L; Cañizares-Alejos S
    Rev Neurol; 2003 Feb 15-28; 36(4):361-5. PubMed ID: 12599136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory neuromodulation of release of amino acid neurotransmitters.
    Peris J; Dunwiddie TV
    Alcohol Drug Res; 1985-1986; 6(4):253-64. PubMed ID: 2868735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional neuroanatomy of brain cannabinoid receptors.
    Breivogel CS; Childers SR
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):417-31. PubMed ID: 9974175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hypothesis for a common neurochemical basis for alcohol and drug disorders.
    Miller NS; Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):105-17. PubMed ID: 8456036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From ion currents to genomic analysis: recent advances in GABAA receptor research.
    Rabow LE; Russek SJ; Farb DH
    Synapse; 1995 Nov; 21(3):189-274. PubMed ID: 8578436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
    Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
    J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The "rut metaphor": a conceptualization of attractor-shaping properties of addictive drugs.
    Zullino DF; Khazaal Y
    Subst Use Misuse; 2008; 43(3-4):469-79. PubMed ID: 18365944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invertebrate models of drug abuse.
    Wolf FW; Heberlein U
    J Neurobiol; 2003 Jan; 54(1):161-78. PubMed ID: 12486703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Methyl-D-aspartate receptors in the ventral tegmental area are involved in retrieval of inhibitory avoidance memory by nicotine.
    Ahmadi S; Zarrindast MR; Nouri M; Haeri-Rohani A; Rezayof A
    Neurobiol Learn Mem; 2007 Oct; 88(3):352-8. PubMed ID: 17707662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotransmitter and drug receptor genes.
    Uhl GR
    NIDA Res Monogr; 1992; 126():14-22. PubMed ID: 1337151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel pharmacological approaches to drug abuse treatment.
    Edens E; Massa A; Petrakis I
    Curr Top Behav Neurosci; 2010; 3():343-86. PubMed ID: 21161760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do specific NMDA receptor subunits act as gateways for addictive behaviors?
    Hopf FW
    Genes Brain Behav; 2017 Jan; 16(1):118-138. PubMed ID: 27706932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors.
    Hurd YL
    CNS Spectr; 2006 Nov; 11(11):855-62. PubMed ID: 17075557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and biochemical evidence for receptors for drugs of abuse on immune cells.
    Liu-Chen LY; Bidlack JM; Rogers TJ; Klein TW; Madden JJ; Sharp BM; Evans CJ
    NIDA Res Monogr; 1996; 162():37-9. PubMed ID: 9066807
    [No Abstract]   [Full Text] [Related]  

  • 38. Laboratory of molecular neurobiology (1988-1994).
    Grayson DR
    Pharmacol Res; 2011 Oct; 64(4):339-43. PubMed ID: 21708255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G protein-coupled receptor heteromers are key players in substance use disorder.
    Derouiche L; Massotte D
    Neurosci Biobehav Rev; 2019 Nov; 106():73-90. PubMed ID: 30278192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug dependence and the endogenous opioid system.
    Gerrits MA; Lesscher HB; van Ree JM
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):424-34. PubMed ID: 14636958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.